Zoetis Inc. filings document the animal health company's operating results, capital returns, financing activity and governance disclosures. Recent 8-K reports furnish quarterly and annual financial results, guidance, dividend declarations, investor presentations and other Regulation FD disclosures.
The company's proxy materials address board and compensation matters, including executive pay and equity-award disclosures. Other filings record its New York Stock Exchange-listed common stock and debt financing, including a private offering of convertible senior notes, related indenture terms and capped call transactions.
Zoetis Inc. Chief Financial Officer Joseph Wetteny reported acquiring 217.6054 phantom stock units on January 9, 2026 at a reference price of $42.42 per unit. After this transaction, he holds a total of 6,803.5995 phantom stock units in a company plan. These units were acquired under the Zoetis Supplemental Savings Plan and are designed to be settled in cash after his separation from service, rather than in actual Zoetis shares.
Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock plus a small cash-equivalent component, which typically makes up around 5% of the unit’s total value. The value of the units is determined by the market value of Zoetis common stock together with the value of the cash-equivalent investments, so their value moves generally in line with the stock over time.
Zoetis Inc. Executive Vice President Rimma Driscoll reported an acquisition of 141.4427 phantom stock units on January 9, 2026. These units were credited at a reference value of $42.42 per unit under the Zoetis Supplemental Savings Plan, bringing her total phantom stock unit balance to 5,367.8047 units held as a direct interest. The phantom stock units are settled in cash after her separation from service, and their value is determined by the market value of Zoetis common stock plus a small portion in cash-equivalent investments, which typically represent around 5% of each unit’s total value.
Zoetis Inc. Executive Vice President Roxanne Lagano reported acquiring 190.4046 phantom stock units on January 9, 2026, at a transaction price of $42.42 per unit. Following this transaction, she beneficially owns 28,815.1316 phantom stock units.
The units were acquired under the Zoetis Supplemental Savings Plan and are settled in cash after her separation from service. Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock plus cash-equivalent investments, which typically make up around 5% of the unit’s total value. The value of these units is determined by the market value of Zoetis common stock and the associated cash-equivalent investments.
Zoetis Inc. executive Julie Fuller reported a new grant of 190.4045 phantom stock units on January 9, 2026. The filing shows the units were acquired at a reference value of $42.42 per unit, bringing her total phantom stock unit balance to 578.0564 held directly.
These phantom stock units were acquired under the Zoetis Supplemental Savings Plan and are settled in cash after her separation from service. Each unit represents a fraction of a phantom share of Zoetis common stock plus a small cash-equivalent component, with the cash-equivalent investments typically around 5% of the unit’s total value. The value of the award therefore tracks the market value of Zoetis common stock together with the related cash-equivalent investments.
Zoetis Inc. reports insider share holdings for Executive Vice President Kevin Esch. As of the reporting date, he directly owns 267 shares of Zoetis common stock and indirectly holds 122.9323 common stock equivalents through the Zoetis Savings Plan, a 401(k) plan, as of December 31, 2025.
He also holds several equity awards: 772.2513, 306.1133, 86.8836 and 50.5137 restricted stock units that generally vest in thirds over three years from grant dates in 2023–2025, plus stock options on 1,181, 490, 545 and 391 shares at exercise prices of $156.64, $196.14, $162.07 and $201.3, typically vesting over three years and expiring ten years from grant. In addition, he holds 176.3958 phantom stock units under a supplemental savings plan that are settled in cash after separation from service.
The Vanguard Group has disclosed a significant ownership stake in Zoetis Inc. Vanguard reports beneficial ownership of 47,778,909 shares of Zoetis common stock, representing 10.84% of the outstanding class as of the reported date. Vanguard has no sole voting power over these shares but shares voting power over 2,768,187 shares. It reports sole dispositive power, meaning the ability to decide when to sell, over 43,395,509 shares and shared dispositive power over 4,383,400 shares.
The shares are held on behalf of Vanguard’s clients, including registered investment companies and other managed accounts, and no single other person has an interest in more than 5% of the class. Vanguard certifies that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of Zoetis.
Zoetis Inc. completed a private offering of $2.0 billion of 0.25% Convertible Senior Notes due 2029. The notes are senior unsecured, pay interest semiannually and are convertible into cash and, at Zoetis’ election, cash, shares or a combination based on an initial conversion rate of 6.7476 shares per $1,000 principal amount, equal to an initial conversion price of about $148.20 per share, a 22.5% premium to the last reported share price on December 15, 2025.
Zoetis expects net proceeds of about $1,969.6 million, allocating approximately $186.6 million to capped call transactions, about $248.0 million to repurchase roughly 2.1 million shares in concurrent private transactions, and about $1,535.0 million for additional share repurchases under its existing $6 billion authorization, which it expects to complete by no later than the first quarter of 2026.
The capped call agreements cover about 13.5 million shares, with strike and cap prices tied to the notes’ conversion economics, and are expected generally to reduce potential dilution or offset cash payments above principal if the notes are converted. Zoetis also obtained a waiver under its revolving credit facility that explicitly permits early conversions of the notes pursuant to their terms.
Zoetis Inc. announced a cash dividend for its common shareholders. The company declared a dividend of $0.53 per share for the first quarter of 2026. This dividend will be paid on March 3, 2026 to shareholders who are on record as owning Zoetis common stock at the close of business on January 20, 2026. The announcement was furnished as a Regulation FD disclosure, meaning it is intended to provide broad, fair access to this information for all investors.
Zoetis Inc. director reports no share ownership in initial filing. A director of Zoetis Inc. (ZTS) filed an initial beneficial ownership statement on Form 3, indicating that they currently hold no non-derivative Zoetis securities, with Table I showing "No securities beneficially held" and an amount of 0. The filing also shows no derivative securities such as options or warrants listed in Table II. The form is filed by a single reporting person and is signed by an attorney-in-fact on their behalf.
Zoetis Inc. disclosed a Form 4 reporting an equity award to one of its directors. On 12/01/2025, the director received 1,964 restricted stock units (RSUs) under the Zoetis Inc. Amended and Restated 2013 Equity and Incentive Plan at an exercise price of $127.25 per unit.
Each RSU represents a contingent right to receive one share of Zoetis common stock. The RSUs are scheduled to vest and be settled in Zoetis common shares on the first anniversary of the grant date, December 1, 2025, provided the director continues to serve through that date, with potential earlier vesting upon certain specified events.